Literature DB >> 15103551

Evidence for non-homologous end joining and non-allelic homologous recombination in atypical NF1 microdeletions.

Marco Venturin1, Cristina Gervasini, Francesca Orzan, Angela Bentivegna, Lucia Corrado, Patrizia Colapietro, Alessandra Friso, Romano Tenconi, Meena Upadhyaya, Lidia Larizza, Paola Riva.   

Abstract

NF1 microdeletion syndrome is caused by haploinsufficiency of the NF1 gene and of gene(s) located in adjacent flanking regions. Most of the NF1 deletions originate by non-allelic homologous recombination between repeated sequences (REP-P and -M) mapped to 17q11.2, while the remaining deletions show unusual breakpoints. We performed high-resolution FISH analysis of 18 NF1 microdeleted patients with the aims of mapping non-recurrent deletion breakpoints and verifying the presence of additional recombination-prone architectural motifs. This approach allowed us to obtain the sequence of the first junction fragment of an atypical deletion. By conventional FISH, we identified 16 patients with REP-mediated common deletions, and two patients carrying atypical deletions of 1.3 Mb and 3 Mb. Following fibre-FISH, we identified breakpoint regions of 100 kb, which led to the generation of several locus-specific probes restricting the atypical deletion endpoint intervals to a few kilobases. Sequence analysis provided evidence of small blocks of REPs, clustered around the 1.3-Mb deletion breakpoints, probably involved in intrachromatid non-allelic homologous recombination (NAHR), while isolation and sequencing of the 3-Mb deletion junction fragment indicated that a non-homologous end joining (NHEJ) mechanism is implicated.

Entities:  

Mesh:

Year:  2004        PMID: 15103551     DOI: 10.1007/s00439-004-1101-2

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  41 in total

1.  A common set of at least 11 functional genes is lost in the majority of NF1 patients with gross deletions.

Authors:  D E Jenne; S Tinschert; E Stegmann; H Reimann; P Nürnberg; D Horn; I Naumann; A Buske; G Thiel
Journal:  Genomics       Date:  2000-05-15       Impact factor: 5.736

Review 2.  A distinctive phenotype associated with an interstitial deletion 6q14 contained within a de novo pericentric inversion 6 (p11.2q15).

Authors:  E Passarge
Journal:  Cytogenet Cell Genet       Date:  2000

3.  Genetic proof of unequal meiotic crossovers in reciprocal deletion and duplication of 17p11.2.

Authors:  Christine J Shaw; Weimin Bi; James R Lupski
Journal:  Am J Hum Genet       Date:  2002-10-09       Impact factor: 11.025

4.  Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2.

Authors:  M Venturin; P Guarnieri; F Natacci; M Stabile; R Tenconi; M Clementi; C Hernandez; P Thompson; M Upadhyaya; L Larizza; P Riva
Journal:  J Med Genet       Date:  2004-01       Impact factor: 6.318

5.  Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females.

Authors:  Ken Inoue; Hitoshi Osaka; Virginia C Thurston; Joe T R Clarke; Akira Yoneyama; Lisa Rosenbarker; Thomas D Bird; M E Hodes; Lisa G Shaffer; James R Lupski
Journal:  Am J Hum Genet       Date:  2002-09-20       Impact factor: 11.025

6.  Dependence of intrachromosomal recombination in mammalian cells on uninterrupted homology.

Authors:  A S Waldman; R M Liskay
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

7.  Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR).

Authors:  L McQuade; J Christodoulou; M Budarf; R Sachdev; M Wilson; B Emanuel; A Colley
Journal:  Am J Med Genet       Date:  1999-09-03

8.  A deletion distinct from the classical homologous recombination of juvenile nephronophthisis type 1 (NPH1) allows exact molecular definition of deletion breakpoints.

Authors:  E Otto; R Betz; C Rensing; S Schätzle; T Kuntzen; T Vetsi; A Imm; F Hildebrandt
Journal:  Hum Mutat       Date:  2000-09       Impact factor: 4.878

9.  Elevated risk for MPNST in NF1 microdeletion patients.

Authors:  T De Raedt; H Brems; P Wolkenstein; D Vidaud; S Pilotti; F Perrone; V Mautner; S Frahm; R Sciot; E Legius
Journal:  Am J Hum Genet       Date:  2003-03-26       Impact factor: 11.025

10.  Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two microdeletions in neurofibromatosis type 1 patients.

Authors:  Nadine Van Roy; Jo Vandesompele; Geert Berx; Katrien Staes; Mireille Van Gele; Els De Smet; Anne De Paepe; Geneviève Laureys; Pauline van der Drift; Rogier Versteeg; Frans Van Roy; Frank Speleman
Journal:  Genes Chromosomes Cancer       Date:  2002-10       Impact factor: 5.006

View more
  17 in total

1.  Identification of an atypical microdeletion generating the RNF135-SUZ12 chimeric gene and causing a position effect in an NF1 patient with overgrowth.

Authors:  Luca Ferrari; Giulietta Scuvera; Arianna Tucci; Donatella Bianchessi; Francesco Rusconi; Francesca Menni; Elena Battaglioli; Donatella Milani; Paola Riva
Journal:  Hum Genet       Date:  2017-08-03       Impact factor: 4.132

2.  Non-recurrent 17p11.2 deletions are generated by homologous and non-homologous mechanisms.

Authors:  Christine J Shaw; James R Lupski
Journal:  Hum Genet       Date:  2004-10-22       Impact factor: 4.132

Review 3.  Mechanisms underlying structural variant formation in genomic disorders.

Authors:  Claudia M B Carvalho; James R Lupski
Journal:  Nat Rev Genet       Date:  2016-02-29       Impact factor: 53.242

4.  Extensively high load of internal tumors determined by whole body MRI scanning in a patient with neurofibromatosis type 1 and a non-LCR-mediated 2-Mb deletion in 17q11.2.

Authors:  Hildegard Kehrer-Sawatzki; Lan Kluwe; Carsten Fünsterer; Victor-Felix Mautner
Journal:  Hum Genet       Date:  2005-03-18       Impact factor: 4.132

5.  Decoding NF1 Intragenic Copy-Number Variations.

Authors:  Meng-Chang Hsiao; Arkadiusz Piotrowski; Tom Callens; Chuanhua Fu; Katharina Wimmer; Kathleen B M Claes; Ludwine Messiaen
Journal:  Am J Hum Genet       Date:  2015-07-16       Impact factor: 11.025

6.  Identification of Alu elements mediating a partial PMP22 deletion.

Authors:  Verena Matejas; Kathrin Huehne; Christian Thiel; Claudia Sommer; Sibylle Jakubiczka; Bernd Rautenstrauss
Journal:  Neurogenetics       Date:  2006-03-29       Impact factor: 2.660

7.  Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination.

Authors:  Katharina Steinmann; David N Cooper; Lan Kluwe; Nadia A Chuzhanova; Cornelia Senger; Eduard Serra; Conxi Lazaro; Montserrat Gilaberte; Katharina Wimmer; Viktor-Felix Mautner; Hildegard Kehrer-Sawatzki
Journal:  Am J Hum Genet       Date:  2007-10-31       Impact factor: 11.025

8.  Detection and characterization of NF1 microdeletions by custom high resolution array CGH.

Authors:  Eric Pasmant; Audrey Sabbagh; Julien Masliah-Planchon; Véronique Haddad; Marie-José Hamel; Ingrid Laurendeau; Jean Soulier; Béatrice Parfait; Pierre Wolkenstein; Ivan Bièche; Michel Vidaud; Dominique Vidaud
Journal:  J Mol Diagn       Date:  2009-09-18       Impact factor: 5.568

9.  Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex.

Authors:  Nassima Fodil-Cornu; Seung-Hwan Lee; Simon Belanger; Andrew P Makrigiannis; Christine A Biron; R Mark Buller; Silvia M Vidal
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

10.  Direct duplication 12p11.21-p13.31 mediated by segmental duplications: a new recurrent rearrangement?

Authors:  Manuela De Gregori; Tiziano Pramparo; Luigi Memo; Giorgio Gimelli; Jole Messa; Mariano Rocchi; Maria Grazia Patricelli; Roberto Ciccone; Roberto Giorda; Orsetta Zuffardi
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.